Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue February 2015
 •  FTC Cracks Down on Melanoma Detection Apps  •  Kohl's To Carry Bliss  •  New Products from Irish Spring  •  Walmart Opens Sustainability Leaders Shop  •  Castanea Invests in Thymes
Print

Merck Mulls Sale Of Coppertone



Published April 29, 2014
Related Searches: companies care business Sun Care
Post a comment
Merck Mulls Sale
Of Coppertone

The sun has set on Merck's sun care business—and its consumer healthcare business, too.


According to reports, Merck could agree a deal to sell its consumer healthcare operations this week for almost $14 billion, with Germany's Bayer and UK-based Reckitt Benckiser the leading companies interested in the unit. Other companies said to be in the running include, Procter & Gamble, Novartis and Sanofi.


Merck is looking to sell the operations as it only holds around 1% of the market.


A deal would be the latest in a wave of blockbuster transactions to have swept the healthcare sector recently, such as Pfizer's $100 billion-plus reported offer to acquire AstroZeneca, Valeant and Bill Ackman's $47 billion play for Allergan, Zimmer's agreement to purchase Biomet for $13.35 billion and a series of deals involving Novartis, GlaxoSmithKline and Eli Lilly.




blog comments powered by Disqus